|
A highly sensitive, low input, and automated assay for molecular residual disease detection (MRD) using whole-genome sequencing (WGS). |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
No Relationships to Disclose |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - I+E Research |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Illumina |
| |
|
|
Stock and Other Ownership Interests - Abbvie; Hologic; Illumina; Pfizer |